SurModics has a total of 1287 patents globally, out of which 633 have been granted. Of these 1287 patents, more than 34% patents are active. The United States of America is where SurModics has filed the maximum number of patents, followed by Europe and Japan. Parallelly, The United States of America seems to be the main focused R&D center and also USA is the origin country of SurModics.
SurModics is subpart of Altria was founded in 1979. The Company engages in the provision of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. The firm operates through the following segments.
Do read about some of the most popular patents of SurModics which have been covered by us in this article and also you can find SurModics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over SurModics patent portfolio.
How many patents does the Founder and CEO of SurModics have?
The CEO Gary R. Maharaj have 17 patents.
How many patents does SurModics have?
SurModics has a total of 1287 patents globally. These patents belong to 292 unique patent families. Out of 1287 patents, 438 patents are active.
How Many Patents did SurModics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Surmodics Applications Filed | Surmodics Patents Granted |
| 2023 | 2 | 13 |
| 2022 | 9 | 24 |
| 2021 | 15 | 51 |
| 2020 | 19 | 50 |
| 2019 | 21 | 39 |
| 2018 | 14 | 30 |
| 2017 | 74 | 33 |
| 2016 | 61 | 26 |
| 2015 | 36 | 30 |
| 2014 | 59 | 40 |
| 2013 | 66 | 25 |
| 2012 | 17 | 32 |
| 2011 | 78 | 24 |
How many SurModics patents are Alive/Dead?
Worldwide Patents
How Many Patents did SurModics File in Different Countries?
Countries in which SurModics Filed Patents
| Country | Patents |
| United States Of America | 341 |
| Europe | 173 |
| Japan | 149 |
| Canada | 106 |
| Germany | 92 |
| Austria | 61 |
| Mexico | 43 |
| Australia | 37 |
| China | 30 |
| India | 20 |
| Brazil | 7 |
| Hong Kong (S.A.R.) | 7 |
| Spain | 6 |
| Russia | 5 |
| Israel | 5 |
| Denmark | 4 |
| Singapore | 4 |
| Korea (South) | 4 |
| Norway | 4 |
| New Zealand | 3 |
| United Kingdom | 3 |
| Costa Rica | 3 |
| Poland | 2 |
| Hungary | 2 |
| Romania | 1 |
| Italy | 1 |
Where are Research Centers of SurModics Patents Located?
10 Best SurModics Patents
US8679454B2 is the most popular patent in the SurModics portfolio. It has received 1078 citations so far from companies like Ethicon Endo-Surgery, Inc, Copilot Ventures Fund and Innovative Surface Technologies.
Below is the list of 10 most cited patents of SurModics:
| Publication Number | Citation Count |
| US8679454B2 | 1078 |
| US6703040B2 | 223 |
| US20060110428A1 | 202 |
| US20060018948A1 | 197 |
| US6689473B2 | 187 |
| US20050143363A1 | 183 |
| US7008667B2 | 173 |
| US7220269B1 | 167 |
| US6514768B1 | 154 |
| US20080081064A1 | 153 |
How many inventions of other companies were rejected due to SurModics patents?
The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to SurModics invention. They couldn’t because SurModics had protected those before them.
Examiners at the USPTO referred 153 SurModics patents in 1066 rejections (35 USC § 102 or 35 USC § 103 types).
The top citing companies in the SurModics patent portfolio are Abbott Cardiovascular Systems, Terumo Kabushiki Kaisha and Covidien.
List of the Companies whose Patents were rejected citing SurModics –
| Company | Number of Patent Applications that faced Rejection Citing SurModics Patents | Number of Rejections (102 & 103) |
| Abbott Cardiovascular Systems | 22 | 42 |
| Terumo Kabushiki Kaisha | 12 | 25 |
| Covidien | 11 | 30 |
| Boston Scientific Scimed | 10 | 29 |
| Lutonix | 10 | 14 |
| Life Technologies | 8 | 10 |
| Urotronic | 7 | 17 |
| C R Bard | 7 | 22 |
| Medtronic Vascular | 7 | 17 |
| Neuravi Limited | 6 | 13 |
Count of 102 and 103 Type Rejections based on SurModics Patents
Top SurModics Patents used in Rejecting Most Patent Applications
| Patent Number | Count of Rejected Applications |
| US20070065484A1 | 15 |
| US8951545B2 | 12 |
| US9827084B2 | 12 |
| US7195913B2 | 11 |
| US8158106B2 | 10 |
| US20110021899A1 | 10 |
| US20060024350A1 | 10 |
| US20060110428A1 | 9 |
| US9295820B2 | 9 |
| US20060018948A1 | 9 |
| US8663674B2 | 9 |
| US7220269B1 | 8 |
| US8512736B2 | 7 |
| US8377461B2 | 7 |
| US7550444B2 | 7 |
What Percentage of SurModics US Patent Applications were Granted?
SurModics (Excluding its subsidiaries) has filed 311 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 205 have been granted leading to a grant rate of 70.45%.
Below are the key stats of SurModics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for SurModics?
| Law Firm | Total Applications | Success Rate |
| Pdsd Law Srdx | 110 | 66.35% |
| Surmodics Kagan Binder | 94 | 67.78% |
| Fredrikson & Byron | 45 | 100.00% |
| Pdsd Law | 13 | 63.64% |
| Merchant & Gould | 10 | 60.00% |
| Surmodics | 9 | 50.00% |
| Kagan Binder | 6 | 40.00% |
| Schwegman Lundberg & Woessner Surmodics | 5 | 100.00% |
| Evonik Corporation | 3 | 0.00% |
| Buchanan Ingersoll & Rooney | 2 | 100.00% |
What are SurModics key innovation segments?
What Technologies are Covered by SurModics?
The chart below distributes patents filed by SurModics